Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

BROKER RATINGS SUMMARY: Credit Suisse Upgrades Experian To Outperform

Wed, 08th Apr 2015 08:36

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday afternoon:
----------
FTSE 100
----------
TRADERS: CREDIT SUISSE RAISES EXPERIAN TO 'OUTPERFORM' ('NEUTRAL')
----------
MORGAN STANLEY RAISES ASTRAZENECA PRICE TARGET TO 4500 (4300) PENCE - 'UNDERWEIGHT'
----------
PANMURE RAISES ST JAMES'S PLACE PRICE TARGET TO 1125 (1057) PENCE - 'BUY'
----------
Liberum Cuts Reed Elsevier Price Target To 1,215p From 1,300p, Retains Buy
----------
TRADERS: JPMORGAN CUTS PRICE TARGET RIO TINTO TO 3450 (3500) PENCE
----------
TRADERS: JPMORGAN CUTS PRICE TARGET BHP BILLITON TO 1600 (1690) PENCE
----------
TRADERS: JPMORGAN CUTS ANGLO AMERICAN PRICE TARGET TO 1040 (1080) PENCE
----------
CHARLES STANLEY RAISES BABCOCK INTERNATIONAL TO 'BUY' ('ACCUMULATE')
----------
FTSE 250
----------
NOMURA CUTS NATIONAL EXPRESS PRICE TARGET TO 260 (280) PENCE - 'REDUCE'
----------
TRADERS: HSBC CUTS NATIONAL EXPRESS TO 'HOLD' (OVERWEIGHT')
----------
NOMURA CUTS STAGECOACH PRICE TARGET TO 430 (440) PENCE - 'BUY'
----------
TRADERS: HSBC RAISES STAGECOACH TO 'BUY' ('HOLD') - TARGET 400 (395) PENCE
----------
NOMURA CUTS FIRSTGROUP PRICE TARGET TO 120 (130) PENCE - 'NEUTRAL'
----------
TRADERS: HSBC CUTS FIRSTGROUP PRICE TARGET TO 110 (120) PENCE - 'HOLD'
----------
NOMURA RAISES GO-AHEAD GROUP TO 'BUY' ('NEUTRAL') - PRICE TARGET 2950 (2550) PENCE
----------
NUMIS CUTS TATE & LYLE TO 'REDUCE' ('HOLD') - TARGET 563 (540) PENCE
----------
UBS RAISES RIGHTMOVE PRICE TARGET TO 3470 (3170) PENCE - 'BUY'
----------
Investec Upgrades AG Barr To Buy From Add, Lifts Price Target To 737p From 714p
----------
MAIN MARKET AND AIM
----------
Investec Raises Robert Walters Price Target To 420p From 390p, Keeps Buy
----------
PANMURE RAISES ROBERT WALTERS PRICE TARGET TO 450 (353) PENCE - 'BUY'
----------
Investec Cuts Parity Group Price Target To 15p From 36p, Retains Buy
----------
Investec Upgrades Gooch And Housego To Buy From Add, Lifts Price Target To 770p From 740p
----------
PANMURE CUTS PORTMEIRION PRICE TARGET TO 1000 (1080) PENCE - 'BUY'
----------
N+1 Singer Upgrades Redcentric To Buy From Hold, Ups Price Target To 168p From 153p
----------
TRADERS: JEFFERIES RAISES BRAMMER PRICE TARGET TO 400 (350) PENCE - 'HOLD'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

Related Shares

More News
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals In...

3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.